COVID-19 N (Nucleocapsid) Protein IgG ELISA Kit

The COVID-19 N (Nucleocapsid) Protein ELISA Kit is a high-quality diagnostic tool designed to detect IgG antibodies against the nucleocapsid protein of SARS-CoV-2 in human serum or plasma samples. The nucleocapsid protein is a vital internal component of the virus, essential for its replication and assembly. This kit provides researchers and clinicians with a reliable solution for identifying immune responses following SARS-CoV-2 infection.

With its high sensitivity and specificity, this ELISA kit ensures accurate detection of antibodies, making it an ideal choice for both clinical research and epidemiological studies. The kit is optimized for ease of use, allowing laboratories to process multiple samples efficiently. Each kit includes pre-coated plates, reagents, and detailed instructions, ensuring consistent and reproducible results.

The nucleocapsid protein, due to its strong immunogenicity, is a key marker for antibody detection. This makes the COVID-19 N Protein ELISA Kit a powerful tool for understanding immunity, monitoring disease progression, and supporting vaccine efficacy studies. Its robust design allows for reliable performance across various testing environments.

Whether you are conducting population-wide seroprevalence studies or assessing individual immune responses, the COVID-19 N Protein ELISA Kit offers a dependable and scalable solution. With Omega Biotechnology’s commitment to innovation and quality, this product sets the standard for reliable diagnostic applications in SARS-CoV-2 research.

The COVID-19 N (Nucleocapsid) Protein IgG ELISA Kit is a versatile tool designed to address a wide range of research and diagnostic needs in the fight against SARS-CoV-2. Its applications extend across seroprevalence studies, diagnostic support, and epidemiological research, making it an essential asset for laboratories and healthcare professionals.

Seroprevalence Studies
This ELISA kit is ideal for determining the percentage of individuals in a population who have been exposed to SARS-CoV-2. By detecting IgG antibodies against the nucleocapsid protein, researchers can assess population immunity levels, track infection rates, and inform public health strategies with reliable data.

Diagnostic Aid
The kit serves as an effective diagnostic aid, enabling the detection of past SARS-CoV-2 infections. Its high sensitivity and specificity ensure accurate identification of antibodies, supporting clinicians in understanding patients’ immune responses and history of exposure.

Epidemiological Research
In epidemiological research, the ELISA kit provides crucial insights into the spread of SARS-CoV-2 within populations. It empowers researchers to monitor transmission dynamics, study outbreak patterns, and evaluate the effectiveness of public health interventions.

By leveraging the COVID-19 N Protein IgG ELISA Kit, laboratories can achieve consistent and reliable results across diverse applications. Omega Biotechnology remains committed to delivering high-quality solutions that advance SARS-CoV-2 research and diagnostics.

High Sensitivity and Specificity
The COVID-19 N Protein IgG ELISA Kit is designed to deliver highly accurate results, ensuring reliable detection of antibodies against the nucleocapsid protein of SARS-CoV-2. This high level of sensitivity and specificity minimizes false positives and negatives, providing users with confidence in their findings. This is especially critical in both clinical diagnostics and research settings where precision is paramount.

Quick and Easy Application
Featuring a user-friendly protocol, this kit simplifies the testing process, making it accessible for laboratories of all sizes. The streamlined steps and ready-to-use reagents enable rapid processing of samples, reducing turnaround time without compromising accuracy. This ensures that results can be obtained efficiently, even in high-throughput settings.

Quantitative and Qualitative Results
The kit provides both quantitative and qualitative measurements of antibody levels, offering comprehensive insights into immune responses. Quantitative data allows for detailed analysis of antibody titers, while qualitative results offer a straightforward indication of exposure. This dual capability makes the kit versatile and suitable for diverse research and clinical objectives.

Broad Application
The COVID-19 N Protein IgG ELISA Kit is a flexible solution, suitable for a wide range of research and clinical applications. It is ideal for seroprevalence studies, epidemiological research, and diagnostic aid, supporting efforts to monitor and manage the impact of SARS-CoV-2. Its adaptability makes it a valuable resource for both small-scale studies and large-scale surveillance programs.

Omega Biotechnology’s commitment to quality ensures that this ELISA kit meets the highest standards, providing reliable and reproducible results across diverse testing environments.

Target
The COVID-19 N (Nucleocapsid) Protein IgG ELISA Kit is specifically designed to detect antibodies against the nucleocapsid protein of SARS-CoV-2. The nucleocapsid protein, a key structural component of the virus, is highly immunogenic, making it a reliable marker for identifying past infections. This makes the kit an invaluable tool for understanding the immune response in individuals who have been exposed to the virus, either through natural infection or vaccination.

Use
The kit is versatile and supports a variety of applications, including:

• Seroprevalence Studies: It enables researchers to determine the percentage of individuals in a population who have been exposed to SARS-CoV-2, offering insights into population immunity and guiding public health strategies.
• Diagnostic Support: By detecting antibodies, the kit aids in diagnosing past SARS-CoV-2 infections, providing clinicians with crucial information about patients’ infection histories.
• Epidemiological Research: The ELISA kit is an essential tool for monitoring the spread of the virus within populations, helping to track outbreak patterns, assess the impact of public health interventions, and inform future response efforts.

With its focus on detecting antibodies against a critical viral protein, this kit is an essential resource for advancing our understanding of SARS-CoV-2 and improving strategies to combat its spread.

96 well plates are coated with specific antigen

Sensitivity: 98.5%

Specificity: 99%

EL-201